If you are interested in participating in a clinical trial or you have a patient you think would benefit from a clinical trial, our research coordinators can work with you to discuss your options and whether immunotherapy is an option for you.
The Divison of Translational Immuno-Oncology at Roswell Park is proud to be among only 28 elite universities and cancer centers in North America that make up the Cancer Immunotherapy Trials Network (CITN), which means access to more treatment options for you.
The CITN works in conjunction with the National Cancer Institute, philanthropic institutions and industry partners, to speed access to the most promising cancer immunotherapies through clinical trials.
Patients eligible through clinical trials may have access to cutting-edge therapies that will boost the immune system’s response to cancer cells.Check Your Eligibility
Clinical trials are designed to evaluate promising new medical treatments. Learn why they might be your best option.Explore the FAQs